Well, it isn't technically dangerous for a false low to shut off the pump.
You're more in danger of your glucose going temporarily higher if say on day 5, as I found 3 times out of five with my box of sensors, the isig starts to fail and you get reported false lows causing the pump suspend to trigger.
In short, I don't use the suspend feature. 60 is too high for a suspend even if it were accurate. Inaccurate - I'm going to have the pump potentially shut off while I'm in the mid to high 100's and continue to escalate while the isig continues to fall, backing up this false corrective measure, so no thanks.
The problems being seen, are seemingly more pronounced for people like me who like to squeeze every life drop out of their supplies. For people who actually change sets every single cycle of 6 days, it seems they're going to see fewer failures and irritations.
My major annoyance was the difference between life from my sofsensors to the Enlite. For my usage it's more expensive as, minimum, I'm going to get 9 days out of a sofsensor, and max, around 24 days (once a 28 day run of usable readings).
In contrast to my view, it also makes those sensors that only lasted to day 5 before giving weird readings seem even more offensive to me.
I see the FDA approval of the suspend feature as being a legal milestone victory towards an automated false pancreas more than a good feature as of itself yet.
What with the delay in actual glucose levels compared to those displayed, and the quirky nature of the signals, the technology just isn't good enough yet to make use of it.
As part of my agreement to upgrade, I'm still being used to give very brief updates on my experience with the pump. These have included a series of 2 questions, the last of which was 'had I experienced any signal loss from the transmitter to the pump?', and 'had the pump failed in any way while delivering?'.
Both my answers to these is of course no. Technically I haven't had those two problems. I have however experienced others you aren't asking me about, but no doubt this will be enough to cover them for their FDA in use inspection as to how the devices are functioning.
Corporate fun and the twisting of words. Bleh.
If I were them I'd be much more worried that a company will produce a pump with an integrated CGM that actually works consistently well.
If I were them I would take another look at that first sofsensor design and try to meld the two and find some middle ground, design-wise. The difference between the two in how they are inserted is night and day - the sofsensor being potentially painful and bloody - the enlite being a masterpiece of comfort and ease. Perhaps the smaller testing surface on the Enlite is also the reason behind it lasting for so much less, also explaining why it bleeds less on insertion.
Finally, the cost difference is a little hard to swallow.
It's essentially the same technology that's been reworked with a nicer inserter style. I don't see how that justifies doubling the cost of them.